Topic: Massachusetts Developments
Massachusetts State Pension Fund Will Not (and Cannot) Form Bond Insurer
Apr 10, 2008 | Massachusetts Developments, Regulatory, Subprime/Credit Crisis Developments | United States
Massachusetts State Court: Insured May Proceed With Bad Faith Claim Even Though Statute of Limitations On Breach of Contract Claim Has Run
Mar 26, 2008 | Coverage & Claims, Extra-Contractual Liability, Massachusetts Developments | United States
Gamache Exception Extended: Massachusetts Trial Court Orders Insurer To Pay Insured’s Attorneys’ Fees In Unsuccessful Duty to Defend Declaratory Judgment Action
Mar 12, 2008 | Coverage & Claims, Massachusetts Developments | United States
A Massachusetts trial court recently held that an insurer must pay the attorneys’ fees incurred by its insured in the successful defense of a duty to defend declaratory coverage action brought by the insurer.
Read MoreUpdate: Massachusetts Managed Competition System for Auto Insurance Rates
Feb 13, 2008 | Massachusetts Developments | United States
The proposed rates of 15 auto insurers have been reviewed and approved by the Massachusetts Division of Insurance since the implementation at the beginning of this year of a “managed competition” system for setting auto insurance rates.
Read MoreHealth Insurers’ Motion to Treble Damages Against Pharmaceutical Companies in Antitrust Case is Granted
Feb 7, 2008 | Antitrust, Healthcare, Illinois Developments, Massachusetts Developments | United States
On June 1, 2005, after a jury trial lasting over three weeks, a jury found for Blue Cross Blue Shield of Massachusetts (“BCBS-MA”), Blue Cross Blue Shield of Minnesota (“BCBS-MN”), Federated Mutual Insurance Company (“Federated”), and Health Care Service Corporation (“HCSC”) (collectively “Plaintiffs”) against Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc., Cambrex Corporation, and Gyma Laboratories (“Defendants”) on state law claims – agreement in unreasonable restraint of trade; conspiracy in unreasonable restraint of trade; monopolization; and, attempted monopolization – in the Lorazepam active pharmaceutical ingredient (“API”) market, Lorazepam tablet market and in the Clorazepate API and tablet markets. The jury awarded BCBS-MA $8,430,887, BCBS-MN $1,756,096, Federated $410,878.00, and HCSC $1,448,437.00 in damages.
Read MoreAggressive New Massachusetts Data Breach Law and Proposed Security Rules Require Company Action
Feb 1, 2008 | Industry Developments, Massachusetts Developments, Privacy/Data Security/Cyber Risk, Regulatory | United States
Massachusetts has become one of the most aggressive states in the country regarding protecting personal data. It has adopted a new data breach law, a new document destruction law and proposed regulations that may represent one of the most far-reaching information security requirements anywhere in the U.S. Taken together, these will have major compliance implications and will likely require more rigorous, written security policies for any company doing business in Massachusetts or holding Massachusetts personal data, wherever located.
Read MoreTexas Attorney General Settles Bid-Rigging Charges With Insurance Carrier
Jan 31, 2008 | Antitrust, Florida Developments, Massachusetts Developments | United States
Massachusetts Attorney General Files Complaint Against Insurer Alleging Bid Rigging
Jan 15, 2008 | Antitrust, Massachusetts Developments | United States
Aggressive New Proposed Regulation for the Security of Personal Information
Jan 14, 2008 | Massachusetts Developments, Privacy/Data Security/Cyber Risk, Regulatory | United States